To our knowledge, only one double-blinded randomized-controlled trial has compared the efficacy and safety of a single intravenous (IV) bolus dose of carbetocin versus IV oxytocin infusion in the prevention of PPH among 180 obese nulliparous women undergoing emergency cesarean delivery [13]. The gene discussed is OXT; the disease is pulmonary arterial hypertension.